Breaking News Instant updates and real-time market news.

AGN

Allergan

$168.96

2.84 (1.71%)

09:02
03/17/18
03/17
09:02
03/17/18
09:02

Allergan shares could rise 20% or more, Barron's says

New competition to Allergan's top product, Botox, and the loss of patent exclusivity for its second biggest, the dry-eye treatment Restasis, have left investors with "worry lines," Vito Racanelli writes in this week's edition of Barron's. However, Racanelli says concerns are over overdone as the company's pipeline of new drugs should eventually replace the lost revenue from products going off patent. The shares could rise 20% or more, to $200-$225 by the end of 2019, Barron's adds. Reference Link

  • 19

    Mar

  • 25

    Mar

  • 05

    Apr

  • 24

    Apr

AGN Allergan
$168.96

2.84 (1.71%)

03/05/18
CANT
03/05/18
INITIATION
Target $25
CANT
Overweight
Evolus initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen started Evolus (EOLS) with an Overweight rating and $25 price target. Physicians want a less costly alternative to Allergan's (AGN) Botox, Chen tells investors in a research note. She expects approval of DWP-450 before the end of the year and notes Evolus is planning to sell the neurotoxin at a 20%-25% discount to Botox.
03/05/18
RHCO
03/05/18
INITIATION
Target $24
RHCO
Buy
Evolus initiated with a Buy at SunTrust
SunTrust analyst John Boris initiated Evolus (EOLS) with a Buy rating and a price target of $24. Boris notes that the company is about its launch it first product DWP-450, targeting the $2B global aesthetic toxin market, adding that the treatment has been de-risked with comparable efficacy to Allergan's (AGN) Botox. The analyst anticipates regulatory approval from the FDA and a soft U.S. launch in Q4 of this year.
03/14/18
RBCM
03/14/18
NO CHANGE
RBCM
Outperform
RBC says Allergan sent clear message that all strategic options being evaluated
RBC Capital analyst Randall Stanicky said that Allergan Chairman and CEO Brent Saunders and new CFO Matt Walsh sent a "clear" message while presenting earlier at an investor conference that all strategic options are being evaluated "with a sense of urgency." This message, which he said is the one he had hoped to hear, will keep the asset sale/break-up debate in the stock, said Stanicky. The analyst, who expects the Street's focus on asset sales to pick up following this, keeps an Outperform rating on Allergan shares.
03/15/18
JPMS
03/15/18
NO CHANGE
Target $265
JPMS
Overweight
Allergan CEO comments on evaluating options a 'clear positive,' says JPMorgan
JPMorgan analyst Chris Schott views Allergan CEO Brent Saunders' comments yesterday on evaluating all options to create value as a "clear positive." The company is focusing on core business execution with a set of near-term pipeline opportunities while also examining other potential value-unlocking options for the business, Schott tells investors in a research note. The analyst says he has long argued that Allergan's core business is "significantly undervalued" and that any shift toward greater Botox/aesthetics exposure would result in a company that trades at a "distinctly higher multiple" than the current business. As such, he believes selling or spinning off assets could unlock value. Schott keeps an Overweight rating on Allergan with a $265 price target.

TODAY'S FREE FLY STORIES

CGC

Canopy Growth

$32.74

1.86 (6.02%)

11:25
08/17/18
08/17
11:25
08/17/18
11:25
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$33.21

0.13 (0.39%)

, VIA

Viacom

$35.75

0.25 (0.70%)

11:19
08/17/18
08/17
11:19
08/17/18
11:19
Hot Stocks
Box Office Battle: 'Crazy Rich Asians' expected to edge out 'The Meg' »

The major release opening…

T

AT&T

$33.21

0.13 (0.39%)

VIA

Viacom

$35.75

0.25 (0.70%)

VIAB

Viacom

$30.60

0.5 (1.66%)

CMCSA

Comcast

$35.59

-0.07 (-0.20%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$44.86

-0.25 (-0.55%)

FOXA

21st Century Fox

$45.41

-0.3 (-0.66%)

LGF.A

Lionsgate

$22.90

-0.16 (-0.69%)

LGF.B

Lionsgate

$21.71

-0.24 (-1.09%)

SNE

Sony

$54.21

0.385 (0.72%)

DIS

Disney

$112.10

-0.39 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 11

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
08/17/18
08/17
11:17
08/17/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
08/17/18
08/17
11:16
08/17/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
08/17/18
08/17
11:15
08/17/18
11:15
General news
Treasury Option Action: put butterfly positioning in the belly »

Treasury Option Action:…

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

11:13
08/17/18
08/17
11:13
08/17/18
11:13
Hot Stocks
The Intersection: Crypto and Wall Street This Week »

As bitcoin, ethereum and…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

TSM

TSMC

$39.87

-0.55 (-1.36%)

NVDA

Nvidia

$247.00

-10.57 (-4.10%)

AMD

AMD

$19.48

0.14 (0.72%)

OSTK

Overstock.com

$30.75

0.55 (1.82%)

DPW

DPW Holdings

$0.42

0.019 (4.76%)

KODK

Kodak

$2.90

-0.1 (-3.33%)

SSC

Seven Stars Cloud Group

$1.99

0.01 (0.51%)

RIOT

Riot Blockchain

$5.35

-0.055 (-1.02%)

TEUM

Pareteum

$2.52

-0.01 (-0.40%)

SRAX

Social Reality

$4.18

-0.16 (-3.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 28

    Aug

  • 12

    Sep

11:05
08/17/18
08/17
11:05
08/17/18
11:05
General news
The U.S. QSS figures »

The U.S. QSS figures that…

NVDA

Nvidia

$247.12

-10.45 (-4.06%)

, ESPR

Esperion

$48.10

1.41 (3.02%)

11:04
08/17/18
08/17
11:04
08/17/18
11:04
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

NVDA

Nvidia

$247.12

-10.45 (-4.06%)

ESPR

Esperion

$48.10

1.41 (3.02%)

DSW

DSW

$25.85

-1.97 (-7.08%)

MTCH

Match Group

$46.87

0.49 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 12

    Sep

  • 12

    Sep

FIBK

First Interstate

$45.20

(0.00%)

11:02
08/17/18
08/17
11:02
08/17/18
11:02
Hot Stocks
First Interstate completes acquisition of Northwest Bancorporation »

Effective August 16,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LB

L Brands

$32.34

0.24 (0.75%)

11:00
08/17/18
08/17
11:00
08/17/18
11:00
Options
Defensive one-week option play in L Brands ahead of earnings »

Defensive one-week option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

SYMC

Symantec

$19.44

0.115 (0.60%)

10:40
08/17/18
08/17
10:40
08/17/18
10:40
Options
Symantec sees in the money put buying »

Symantec sees in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

DE

Deere

$136.75

-0.63 (-0.46%)

10:39
08/17/18
08/17
10:39
08/17/18
10:39
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere says cash use…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

TSLA

Tesla

$313.73

-21.73 (-6.48%)

10:37
08/17/18
08/17
10:37
08/17/18
10:37
Technical Analysis
Technical Take: Tesla nearing bearish head and shoulders target »

In a note published here…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

PK

Park Hotels & Resorts

$32.15

-0.19 (-0.59%)

10:36
08/17/18
08/17
10:36
08/17/18
10:36
Hot Stocks
Park Hotels & Resorts mentioned positively by Hedgeye »

Hedgeye made positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
08/17/18
08/17
10:35
08/17/18
10:35
General news
FX Action: Cable is set to rack up a sixth consecutive week of declines »

FX Action: Cable is set…

WBK

Westpac Banking

$21.99

0.09 (0.41%)

10:33
08/17/18
08/17
10:33
08/17/18
10:33
Downgrade
Westpac Banking rating change  »

Westpac Banking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

DE

Deere

$137.29

-0.09 (-0.07%)

10:31
08/17/18
08/17
10:31
08/17/18
10:31
Hot Stocks
Deere expects FY18 net operating cash flows from equipment operations $3.5B »

Says had another…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

SPY

SPDR S&P 500 ETF Trust

$283.54

-0.55 (-0.19%)

10:30
08/17/18
08/17
10:30
08/17/18
10:30
Options
Bullish end of year play in SPYders »

Bullish end of year play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
08/17/18
08/17
10:25
08/17/18
10:25
General news
The Michigan sentiment drop to an 11-month low »

The Michigan sentiment…

GERN

Geron

$3.99

0.04 (1.01%)

10:20
08/17/18
08/17
10:20
08/17/18
10:20
Options
Geron draws far upside call buyers »

Geron draws far upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

10:20
08/17/18
08/17
10:20
08/17/18
10:20
General news
U.S. leading indicator rose 0.6% to 110.7 in July »

U.S. leading indicator…

DARE

Dare Bioscience

$1.01

0.01 (1.00%)

, WSC

WillScot

$16.10

0.2 (1.26%)

10:18
08/17/18
08/17
10:18
08/17/18
10:18
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

DARE

Dare Bioscience

$1.01

0.01 (1.00%)

WSC

WillScot

$16.10

0.2 (1.26%)

LGND

Ligand

$237.18

-2.66 (-1.11%)

COT

Cott Corp.

$15.98

0.34 (2.17%)

AZRE

Azure Power

$15.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

DF

Dean Foods

$8.01

-0.62 (-7.18%)

, WAB

Wabtec

$108.87

-1.73 (-1.56%)

10:17
08/17/18
08/17
10:17
08/17/18
10:17
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

DF

Dean Foods

$8.01

-0.62 (-7.18%)

WAB

Wabtec

$108.87

-1.73 (-1.56%)

YUMC

Yum China

$34.48

-0.85 (-2.41%)

DSW

DSW

$25.77

-2.05 (-7.37%)

SUI

Sun Communities

$101.22

-0.895 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Sep

  • 12

    Sep

  • 06

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/17/18
08/17
10:17
08/17/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/17/18
08/17
10:16
08/17/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.